FDA Authorizes Vuse Devices: Solo & Alto (Timeline + What It Means)

It’s official: the U.S. Food & Drug Administration (FDA) has authorized multiple Vuse products through the PMTA pathway first Vuse Solo in October 2021, then Vuse Alto in July 2024. Below we explain what’s authorized, what isn’t, and how to choose between Vuse Solo and Vuse Alto for your needs.

What exactly did the FDA authorize?

Want the flavor differences? See Golden Tobacco vs. Rich Tobacco.

Why were hundreds of other applications denied?

Since 2021, the FDA has denied large numbers of flavored products that didn’t demonstrate a net benefit for adult smokers relative to risks to youth. That’s why the authorizations above are limited to tobacco flavors.

Solo vs Alto: which Vuse is right for you?

Related reads

FAQs

  1. Which Vuse products are FDA-authorized?
    Vuse Solo (device + two tobacco cartridges) and Vuse Alto (device + six tobacco pods: Golden Tobacco & Rich Tobacco in 1.8%, 2.4%, 5.0%).
  2. Are any Vuse menthol pods authorized?
    No. As of the July 18, 2024 decision, only tobacco flavors for Vuse were authorized.
  3. Why are so many flavored vapes denied?
    The FDA requires robust evidence that benefits to adult smokers outweigh risks to youth; many flavored products didn’t meet that bar.

Editor’s note: Updated November 12, 2025 to reflect FDA decisions through 2024 and add shopping links.

The post FDA Authorizes Vuse Devices: Solo & Alto (Timeline + What It Means) appeared first on Blog Vape-Ecigs.